Literature DB >> 17435629

Bupropion normalizes cognitive performance in patients with depression.

C Thomas Gualtieri1, Lynda G Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17435629      PMCID： PMC1924979     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  16 in total

1.  Changes in cognitive functioning following treatment of late-life depression.

Authors:  M A Butters; J T Becker; R D Nebes; M D Zmuda; B H Mulsant; B G Pollock; C F Reynolds
Journal:  Am J Psychiatry       Date:  2000-12       Impact factor: 18.112

2.  Neurocognition in depression: patients on and off medication versus healthy comparison subjects.

Authors:  C Thomas Gualtieri; Lynda G Johnson; Kenneth B Benedict
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

3.  Psychopharmacological effects of sertraline in normal, healthy volunteers.

Authors:  I Hindmarch; J Z Bhatti
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers.

Authors:  P M Furlan; M J Kallan; T Ten Have; B G Pollock; I Katz; I Lucki
Journal:  Am J Geriatr Psychiatry       Date:  2001       Impact factor: 4.105

5.  [Do cognitive deficits in depressive disorders remit?].

Authors:  K Frasch; S Bretschneider; C Bullacher; R Hess; R Wittek; N U Neumann
Journal:  Psychiatr Prax       Date:  2000-09

6.  Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors.

Authors:  J A Schmitt; M J Kruizinga; W J Riedel
Journal:  J Psychopharmacol       Date:  2001-09       Impact factor: 4.153

7.  The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance.

Authors:  J S Kerr; J Powell; I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1996-08       Impact factor: 4.335

8.  Fluoxetine-induced memory impairment in an adolescent.

Authors:  M E Bangs; T A Petti; M D Janus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Nov-Dec       Impact factor: 8.829

9.  Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia.

Authors:  D V Jeste; S C Heaton; J S Paulsen; L Ercoli; J Harris; R K Heaton
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  An investigation of the effects of lofepramine, nomifensine, amitriptyline and placebo on aspects of memory and psychomotor performance related to car driving.

Authors:  I Hindmarch; C Harrison; C A Shillingford
Journal:  Int Clin Psychopharmacol       Date:  1988-04       Impact factor: 1.659
View more
  8 in total

1.  Exploration of 100 commonly used drugs and supplements on cognition in older adults.

Authors:  Karen R Obermann; John C Morris; Catherine M Roe
Journal:  Alzheimers Dement       Date:  2013-08-15       Impact factor: 21.566

2.  Effects of bupropion sustained release on task-related EEG alpha activity in smokers: Individual differences in drug response.

Authors:  Jian Zhu; Ryan P Coppens; Norka E Rabinovich; David G Gilbert
Journal:  Exp Clin Psychopharmacol       Date:  2017-02       Impact factor: 3.157

3.  Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion.

Authors:  Marianne Gorlyn; John Keilp; Ainsley Burke; Maria Oquendo; J John Mann; Michael Grunebaum
Journal:  Psychiatry Res       Date:  2014-12-13       Impact factor: 3.222

Review 4.  Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment.

Authors:  Rebecca L Ashare; Mary Falcone; Caryn Lerman
Journal:  Neuropharmacology       Date:  2013-04-29       Impact factor: 5.250

Review 5.  Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.

Authors:  Raymond W Lam; Sidney H Kennedy; Roger S Mclntyre; Atul Khullar
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

6.  Enhancement of nootropic effect of duloxetine and bupropion by caffeine in mice.

Authors:  Pravin Popatrao Kale; Veeranjaneyulu Addepalli
Journal:  Indian J Pharmacol       Date:  2015 Mar-Apr       Impact factor: 1.200

Review 7.  Paying attention to attention in depression.

Authors:  Arielle S Keller; John E Leikauf; Bailey Holt-Gosselin; Brooke R Staveland; Leanne M Williams
Journal:  Transl Psychiatry       Date:  2019-11-07       Impact factor: 6.222

Review 8.  Cognitive remission: a novel objective for the treatment of major depression?

Authors:  Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2016-01-22       Impact factor: 8.775
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.